Multimodality imaging of the parathyroid glands in primary hyperparathyroidism

Minerva Endocrinologica

Volumn 33, Issue 3, 2008, Pages 193-202

  Shah, S ^a   Win, Z ^a,b   Al Nahhas, A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b HILLINGDON HOSPITAL   (United Kingdom)

Author keywords

Hyperparathyroidism, primary; Parathyroid diseases; Radionuclide imaging; Surgical procedures, minimally invasive; Technetium Tc 99m sestamibi

Indexed keywords

IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PERTECHNETIC ACID TC 99M; TECHNETIUM 99M; THALLIUM 201; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID ADENOMA; PARATHYROID HYPERPLASIA; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION; ADENOMA; FEMALE; HYPERPARATHYROIDISM; IMAGE SUBTRACTION; MALE; METHODOLOGY; PARATHYROID GLAND; PARATHYROID TUMOR; PRENATAL DEVELOPMENT; PREOPERATIVE CARE; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADENOMA; DIAGNOSTIC IMAGING; FEMALE; HUMANS; HYPERPARATHYROIDISM; MAGNETIC RESONANCE IMAGING; MALE; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149394534     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Palestro CJ, Tomas MB, Tronco GG. Radionudide imaging of the parathyroid glands. Semin Nucl Med 2005;35:266-76.
2. Health H 3rd, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Eng J Med 1980;302:189-93.
3. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17(Suppl 2):N18-23.
4. Heath H 3rd. Primary hyperparathyroidism: recent advances in pathogenesis, diagnosis, and management. Adv Intern Med 1992;37:275.
5. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132:359-72.
6. Baliski CR, Stewart JK, Anderson DW, Wiseman SM, Bugis SP. Selective unilateral parathyroid exploration: an effective treatment for primary hyperparathyroidism. Am J Surg 2005;189:596-600.
7. Inabnet WB, Fulla Y, Richard B, Bonnichon P, Icard P,Chapuis Y. Unilateral neck exploration under local anaesthesia: the approach of choice for asymptomatic primary hyperparathyroidism. Surgery 1999;126:1004-10.
8. Smith PC, Rinkes IH, van Dalen A, van Vroonhoven TJ. Direct, minimally invasive adenomectomy for primary hyperparathyroidism: an alternative to conventional neck exploration? Ann Surg 2000;231:559-65.
9. Udelsman R, Donovan PI, Sokoll LJ. One hundred consecutive minimally invasive parathyroid explorations. Arch Surg 2000;31:1074-8.
10. Ryan Jr JA, Eisenberg B, Pado KM, Lee F. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests. Arch Surg 1997;132:886-91.
11. Dyson M. Endocrine system. In: Williams PL, editor. Gray's anatomy. 38th ed. New York: Churchill Livingstone; 1995. p. 1881-907.
12. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery 1984;95:14-21. (Pubitemid 14215453)
13. Wang C. The anatomic basis of parathyroid surgery. Ann Surg 1976;183:271-5.
14. Yao K, Singer FR, Roth SI, Sassoon A, Ye C, Giuliano AE. Weight of normal parathyroid glands in patients with parathyroid adenomas. J Clin Endorinol Metab 2004;89:3208-13.
15. Mollerup CL, Bollerslev J, Blichert-Toft M. Primary hyperparathyroidism: incidence and clinical and biochemical characteristics - a demographic study. Eur J Surg 1994;160:485-9.
16. Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR 2007;188:1706-15.
17. Merrick MV. Endocrine. In: Merrick MV, editor. Essentials of nuclear medicine. 2nd ed. Berlin: Springer-Verlag; 1998. p. 149-76.
18. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001;28: 209-13.
19. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801-7.
20. Hindie E, Melliere D, Jeanguillaume C, Perlemuter L, Chehade F, Galle P. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med 1998;39:1100-5.
21. Kettle AG, O'Doherty MJ. Parathyroid imaging: how good is it and how should it be done? Semin Nucl Med 2006;36:206-11.
22. Ahuja AT, Wong KT, Ching AS, Fung MK, Lau JY, Yuen EH et al. Imaging for primary hyperparathyroidism - what beginners should know. Clin Radiol 2004;59:967-76.
23. Moinuddin M, Whynott C. Ectopic parathyroid adenomas: multi-imaging modalities and its management. Clin Nucl Med 1996;21:27-32.
24. Billotey C, Sarfati E, Aurengo A, Duet M, Mundler O, Touber ME et al. Advantages of SPECT in technetium-99m sestamibi parathyroid scintigraphy. J Nucl Med 1996;37:1773-8.
25. Rubello D, Casara D, Pagetta C, Piotto A, Pelizzo MR, ShapiroB. Determinant role of Tc-99m SPECT in the localization of a retropharyngeal parathyroid adenoma successfully treated by radioguided surgery. Clin Nucl Med 2002;27:711-5.
26. O'Doherty MJ, Kettle AG, Wells P, Collins RE, Coakley AJ. Parathyroid imaging with technetium-99m sestamibi: pre-operative localization and tissue uptake studies. J Nucl Med 1992;33:313-8.
27. Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 2004;136:872-80.
28. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 2007;48:1084-9.
29. Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 2002;131:149-57.
30. Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE et al. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology 1996;201:85-91.
31. Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual phase sestamibi for parathyroid adenoma detection. Clin Nud Med 2005;30:1-3. (Pubitemid 40039571)
32. Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Technetium 99m-MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000;128:29-35. (Pubitemid 30456892)
33. Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD et al. The value of 99m-Tc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas and hyperplasia. J Nucl Med 2005;46:248-52.
34. Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R et al. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 2006;30:76-83.
35. Profanter C, Wetscher GJ, Gabriel M, Sauper T, Rieger M, Kovacs P et al. CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism. Surgery 2004;135:157-62.
36. Gooding GAW. Sonography of the thyroid and parathyroid. Radiol Clin North Am 1993;31:967-89.
37. Reading CC, Charboneau JN, James EM, Karsell PR, Purnell DC, Grant CS et al. High resolution parathyroid sonography. AJR 1982;139:539-46.
38. Randel SB, Gooding GAW, Clark OH, Stein RM, Winkler B. Parathyroid variants: US evaluation. Radiology 1987;165:191-4.
39. Fugazzola C, Bergamo AI, Andreis I, Solbiati L. Parathyroid glands. In: Solbiati L, Rizzatto G, editors. Ultrasound of superficial structures. London: Churchill Livingstone; 1995. p. 87-114.
40. Lane MJ, Desser TS, Weigel RJ, Jeffrey RB. Use of color and power Doppler sonography to identify feeding arteries associated with parathyroid adenomas. AJR Am J Roentgenol 1998;171:819-23.
41. Reeder SB, Desser TS, Weigel RJ, Jeffrey RB. Sonography in primary hyperparathyroidism: review with emphasis on scanning technique. J Ultrasound Med 2002;21:539-52.
42. Krubsack AJ, Wilson SD, Lawson TL, Kneeland JB, Thorsen MK, Collier BD et al. Prospective comparison of radionuclide, computed tomographic, sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 1989;106:639-46.
43. Koslin DB, Adams J, Andersen P, Everts E, Cohen J. Preoperative evaluation of patients with primary hyperparathyroidism: role of high resolution ultrasound. Laryngoscope 1997;107:1249-53.
44. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperativelocalization of enlarged parathyroid glands in primaryhyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 2002;57:241-9.
45. Rickes S, Sitzy J, Neye H, Ocran KW, Wermke W. High-resolution ultrasound in combination with colour-Doppler sonography for preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism. Ultraschall Med 2003;24:85-9.
46. Mazzeo S, Caramella D, Marcocci C, Lonzi S, Cambi L, Miccoli P et al. Contrast-enhanced color Doppler ultrasonography in suspected parathyroid lesions. Acta Radiol 2000;41:412-6.
47. Loevner LA. Imaging of the parathyroid gland. Semin Ultrasound CT MR 1996;17:563-75.
48. Adams JE, Adams PH, Mamtora H, Isherwood I. Computed tomography and the localization of parathyroid tumours. Clin Radiol 1981;32:251-4.
49. Gotway MB, Higgins CB. MR imaging of the thyroid and parathyroid glands. Magn Reson Imaging Clin N Am 2000;8:163-82.
50. Gotway MB, Reddy GP, Webb WR, Morita ET, Clark OH, Higgins CB. Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent or persistent hyperparathyroidism. Radiology 2001;218:783-90.
51. Wright AR, Goddard PR, Nicholson S, Kinsella DC, Davies ER, Farndon JR. Fat suppression magnetic resonance imaging in the preoperative localization of parathyroid adenomas. Clin Radiol 1992;46:324-8.
52. Auffermann W, Guis M, Tavares NJ, Clark OH, Higgins CB. MR signal intensity of parathyroid adenomas: correlation with histopathology. AJR 1989;153:873-6. (Pubitemid 19243800)
53. Lopez Hanninen E, Vogl TJ, Steinmuller T, Ricke J, Neuhaus P, Felix R. Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest Radiol 2000;35:426-30.
54. Solorzano CC, Carneiro-Pla DM, Irvin GL 3rd. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic and primary hyperparathyroidism. J Am Coll Surg 2006;202:18-24.
55. van Dalen A, Smit CP, van Vroonhoven TJ, Burger H, de Lange EE. Minimally invasive surgery for solitary parathyroid adenomas in patients with primary hyperparathyroidism: role of US with supplemental CT. Radiology 2001;220:631-9.